To measure serum levels of bevacizumab and to compare serum levels of free vascular endothelial growth factor ( VEGF ) and insulin-like growth factor-@ ( IGF-@ ) in infants who were treated with either intravitreal injection of bevacizumab ( IVB ) or laser for type @ retinopathy of prematurity ( ROP ) .